Mollugo pentaphylla: New nutraceutical use as antidiabetic
Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), K. R. Palli cross, Chiyyedu (Post), Anantapur, Andhrapradesh – 515721, India.
Review
International Journal of Scholarly Research in Multidisciplinary Studies, 2023, 03(01), 038–041.
Article DOI: 10.56781/ijsrms.2023.3.1.0069
Publication history:
Received on 17 May 2023; revised on 15 July 2023; accepted on 17 July 2023
Abstract:
Nutraceuticals are the emerging era in the treatment of diabetes mellitus, one of the seriously problematic due to leading the causes of death in all over the world. The newer anti-hyperglycemic drugs continue searching because the existing synthetic drugs have several limitations. Traditional medicinal plants are used in the treatment of diabetes mellitus more than a century, but only a few of these have proofed their safe and efficacious. The aim of this review article is focused Mollugo pentaphylla one of the medicinal plants used for antioxidant activities. It contains several kinds of alkaloids, flavonoids, saponins, tannin, diterpenes, triterpenoids, glycosides and phenols. Many researchers have evaluated that these phytochemical substances have the major impact on diabetes mellitus. This review focuses on the hypoglycemic activity of this plant and clears that it has the potential to be considered as a candidate for preparing the new treatment of diabetes mellitus.
Keywords:
Diabetes mellitus; Hypoglycemia; Mollugo pentaphylla; Nutraceutical; Plant
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0